Skip to content

Bioequivalence study of GP-IMP-001 with regards to reference product

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-515889-14-00
Acronym
Gebro-I-56.1
Enrollment
24
Registered
2024-12-19
Start date
2025-01-22
Completion date
2025-02-26
Last updated
2025-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

None listed

Sponsors

Gebro Pharma GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

Czechia

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026